Hulya Ertas

Bursa, 16000, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Prognostic Value of Immunonutritional Status and Radiologic Muscle Mass in Older Patients Receiving Immune Checkpoint Inhibitors: A Real-World Study.

Prognostic Value of Immunonutritional Status and Radiologic Muscle Mass in Older Patients Receiving Immune Checkpoint Inhibitors: A Real-World Study.

Journal: Current oncology (Toronto, Ont.)

Published: June 05, 2026

Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study.

Predictors of hepatotoxicity in patients receiving CDK4/6 inhibitors: A real-world cohort study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: May 14, 2026

Psychological impact of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer: Insomnia, anxiety and menopausal symptoms assessed by the Nottingham health profile.

Psychological impact of CDK4/6 inhibitors in HR+/HER2- advanced breast cancer: Insomnia, anxiety and menopausal symptoms assessed by the Nottingham health profile.

Journal: Irish journal of medical science

Published: August 02, 2025

Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma.

Hyperprogression and hypercalcemia after nivolumab treatment in three cases with renal cell carcinoma.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: February 21, 2022

Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations.

Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations.

Journal: World journal of gastrointestinal oncology

Published: June 17, 2020

Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy.

Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy.

Journal: World journal of clinical oncology

Published: September 25, 2018

Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status.

Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status.

Journal: World journal of clinical cases

Published: April 10, 2018

Shattering the castle walls: Anti-stromal therapy for pancreatic cancer.

Shattering the castle walls: Anti-stromal therapy for pancreatic cancer.

Journal: World journal of gastrointestinal oncology

Published: March 30, 2018

Platinum-induced neurotoxicity: A review of possible mechanisms.

Platinum-induced neurotoxicity: A review of possible mechanisms.

Journal: World journal of clinical oncology

Published: April 10, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026